
    
      Since influenza vaccination is recommended in the age range of the study population, Fluarixâ„¢
      (GlaxoSmithKline Biologicals) vaccine will be offered free of charge for the study period (3
      consecutive years), to be used by Investigators according to national vaccination
      schedule/practice.

      The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007
    
  